Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Psilocybin Work Group
The 2022 Washington State Legislature directed the Health Care Authority (HCA) to create a work group to study whether to make psilocybin services available in Washington. A growing body of research suggests psilocybin may be effective in the treatment of some behavioral health conditions.
About the work group
The work group works to:
- Review Oregon’s proposed rules for the regulation of psilocybin and assess the impact the adoption of similar laws and rules would have in our state, and identify areas where a different approach may be necessary or desirable.
- Review Liquor and Cannabis Board systems and procedures to monitor manufacturing, testing, and tracking of cannabis to determine whether they are suitable for use with psilocybin.
- Review the social opportunity program proposed in Senate Bill 5660 for the purpose of recommending improvements or enhancements to promote equitable access to legal psilocybin.
- Review options to integrate licensed behavioral health professionals into the practice of psilocybin therapy where appropriate.
- Deliver a preliminary report to the Governor and Legislature by December 1, 2022, and a final report by December 1, 2023.
Meeting details
|
Date |
Details and materials |
|---|---|
|
June 30, 2022 |
|
|
August 4, 2022 |
|
|
October 31, 2022 |
|
| December 2, 2022 | |
|
February 13, 2023 |
|
|
April 24, 2023 |
|
| June 26, 2023 | |
| August 28, 2023 | |
| October 5, 2023 |
Contact
Email: HCA Psilocybin Work Group